While the body naturally produces glutathione, levels fluctuate and decline due to poor nutrition, stress, improper rest, ...
A woman with multiple sclerosis (MS) has become the first person in the UK to receive a new "game-changer" 10-minute ...
Patients will be able to get a 10 minute injection of the Roche drug, instead of an hours-long infusion. Novartis already has ...
IV Nutrition opened in Lakehills Plaza in South Austin on Aug. 19. The medical spa is locally owned by Sabira Karovalia and ...
Rising Pharmaceuticals, Inc. announces commercial availability of Edetate calcium disodium injection in the United States ...
Vitamin drips, also known as Intravenous Vitamin (IV) therapy, have gained popularity in recent years, especially during the ...
Subcutaneous administration of ocrelizumab was noninferior to intravenous infusion in the phase 3 OCARINA II trial.
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug ...
Ocrelizumab also helps to prevent Multiple Sclerosis (MS) relapses. The new method has been used at Swansea Bay University ...
Repeated Intravenous Infusion of Biopsy Bone Marrow from a ... patient's white-cell count occurring at the time of the last 3 marrow injections and the plateau in the hemoglobin level occurring ...
The U.S. Food and Drug Administration on Thursday approved Roche's under-the-skin injection to treat patients with multiple ...